Advertisement

Topics

Progenics Pharmaceuticals Inc. (PGNX) Receives New Coverage from Analysts at Cantor Fitzgerald

03:43 EDT 30 Jul 2017 | Topix

The brokerage issued an overweight rating and a $15.00 price objective on the biotechnology company's stock. Several other research analysts also recently issued reports on the stock.

Original Article: Progenics Pharmaceuticals Inc. (PGNX) Receives New Coverage from Analysts at Cantor Fitzgerald

NEXT ARTICLE

More From BioPortfolio on "Progenics Pharmaceuticals Inc. (PGNX) Receives New Coverage from Analysts at Cantor Fitzgerald"

Quick Search
Advertisement
 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...